Trienamine catalyzed asymmetric synthesis and biological investigation of a cytochalasin B-inspired compound collection

11Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

Due to their enhanced metabolic needs many cancers need a sufficient supply of glucose, and novel inhibitors of glucose import are in high demand. Cytochalasin B (CB) is a potent natural glucose import inhibitor which also impairs the actin cytoskeleton leading to undesired toxicity. With a view to identifying selective glucose import inhibitors we have developed an enantioselective trienamine catalyzed synthesis of a CB-inspired compound collection. Biological analysis revealed that indeed actin impairment can be distinguished from glucose import inhibition and led to the identification of the first selective glucose import inhibitor based on the basic structural architecture of cytochalasin B.

Cite

CITATION STYLE

APA

Sellstedt, M., Schwalfenberg, M., Ziegler, S., Antonchick, A. P., & Waldmann, H. (2015). Trienamine catalyzed asymmetric synthesis and biological investigation of a cytochalasin B-inspired compound collection. Organic and Biomolecular Chemistry, 14(1), 50–54. https://doi.org/10.1039/c5ob02272j

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free